The only 15-day CGM technology that connects to all leading pump brands in the US¹

The FreeStyle Libre 3 system includes the Libre 3 Plus sensor, Libre 3 sensor, Libre 3 app, Libre App, and the Libre 3 reader.

The FreeStyle Libre 3 Plus sensor is indicated for use in people with diabetes age 2 and older.

Omnipod 5 is intended for use in people with type 1 diabetes ages 2 and older and in type 2 diabetes ages 18 and older in the US.

* Based on sensor features including up to 15-day wear period, automatic readings every minute, accuracy data, and single-app setup with AID systems.

‡ The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Personal Diabetes Manager and Controller are not waterproof.

§ The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.

|| Check the Support section of www.librelinkup.com for information about mobile device and operating system compatibility. LibreLinkUp is not intended to be used for dosing decisions or to replace self-monitoring practices as advised by a physician and requires registration with LibreView.

¶ In order to receive alarms the FreeStyle Libre 3 Plus sensor must be connected to the Omnipod 5 System.

♢ Eligible patients will receive one (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor for users with a compatible mobile phone operating system at $0 copay. The expiration date of the voucher is 60 days from the issue date. This program is available for patients with Type 1 diabetes or Type 2 diabetes or gestational diabetes. Patients ages 18 and older are eligible to sign up and receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor. Patients ages 2–17 are eligible to receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor through their parent or guardian. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Kaiser Permanente, Medicare, Medicaid or other federal or state healthcare programs, residents of Massachusetts, or US territories (other than Puerto Rico). The free (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor is provided as a sample and is limited to one sample per eligible person per product identification number. The FreeStyle Libre 2 Plus sensor or FreeStyle Libre 3 Plus sensor cannot be re-sold, traded nor submitted to any third-party payer for reimbursement and is not provided as any inducement for future purchases. The free sample card is not health insurance.

References: 1. Data on file. Abbott Diabetes Care, Inc. 2. Brown, Sue A., et al. “Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.” Diabetes Care, 44, no. 7 (2021): 1630–1640. https://doi.org/10.2337/dc21-0172. 3. Sherr, Jennifer L., et al. “Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial.” Diabetes Care 45, no. 8 (2022): 1907–1910. https://doi.org/10.2337/dc21-2359. 4. Pasquel, Francisco J., et al. “Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.” JAMA Network Open 8, no. 2 (2025): e2459348. https://doi.org/10.1001/jamanetworkopen.2024.59348.